There was good concordance between SLC7A11 (which encodes xCT), NQO1, GCLC and GCLM median expression levels across tumours (Fig. 5a), providing an ‘antioxidant signature’ associated with the NRF2 transcriptional program. The gene discussed is SLC7A11; the disease is neoplasm.